The commercial gap that kills clean tech businesses, and what boards keep missing

I have spent enough time in clean tech to know how the story usually goes.

The science is sound. The funding has landed. The team is full of clever, committed people who can explain the technology better than almost anyone in the room. And still, eighteen months on, the business is not where the plan said it would be.

When I am asked to look at a business in that position, people expect me to start with the product. I rarely do. The product is almost never the reason a clean tech company stalls. The reason is a gap between what the business has built and what it can actually sell, at a price that works, to a customer who is ready to buy. I call it the commercial gap, and it is the most expensive blind spot in the sector.

Here is what the gap looks like in practice. A company raises on the strength of its technology. The pitch is technical, the diligence is technical, and the early hires are technical. Everyone is optimising the thing that already works. Meanwhile the questions that decide whether the business survives go unasked. Who is the buyer, and what is their real decision process? Are we selling an outcome or an explanation? Does our pricing reflect the value we create or the cost we incurred? Are we winning customers, or winning pilots that never convert?

None of these are technology questions. All of them are commercial questions. And in most of the businesses I see, no one in a position of authority owns them.

This is where boards come in, and where boards keep missing it. A clean tech board is often a remarkable collection of scientific and engineering talent. That is a strength when the work is proving the technology. It becomes a weakness the moment the business needs to commercialise. A board that understands the science intimately will instinctively protect the science. It will fund another development cycle before it funds a commercial hire. It will read a slow pipeline as a marketing problem rather than a sign that the offer itself is wrong. And it will do all of this with the best intentions, because it is drawing on the expertise in the room, and the expertise in the room is technical.

The result is a board that is well informed and badly balanced. It can tell you everything about how the product works and very little about whether the business does.

I have sat on boards where the turning point was simply the arrival of one person whose job was to ask commercial questions without apology. Not to doubt the technology, but to insist that the technology is not the same thing as the business. That single change in composition often does more for a company's prospects than another round of funding.

For an investor, the commercial gap is not an abstraction. It is the difference between a business that returns the fund and one that quietly absorbs it. The gap rarely shows up in a deck, because a deck is built to showcase the technology. It shows up in the questions a founder cannot answer cleanly. Ask how they arrived at their pricing and listen for whether the answer describes the market or describes their costs. Ask who has bought, not who is interested. Ask what happens to the unit economics at ten times the volume. A founder who has closed the commercial gap answers these without flinching. A founder who has not will talk about interest rather than purchase, and about cost rather than value. Those two substitutions are the signal, and they show up long before the numbers confirm them.

The commercial gap is not a failure of intelligence - the people running these businesses are some of the sharpest I have worked with. It is a failure of attention. Capital, talent and board focus all flow towards the part of the business that is already working, and away from the part that decides whether any of it matters.

Closing the gap is not complicated, but it does require a decision most founders and boards delay too long. Bring commercial judgement into the business, and onto the board, while the technology is still being proven, not after the pipeline has stalled. Treat the route to market as seriously as the route to a working product. And accept that the question was never whether the innovation is good. It is whether the organisation around it can turn that innovation into a business.

Most clean tech companies do not fail because the innovation is wrong. They fail because the organisation cannot turn it into something a customer will pay for, fast enough to matter. The technology was never the hard part. The commercial decisions around it always were.

If your board can describe your technology in detail but not your buyer, you already know which gap to close first.

I speak to boards, founders and investor audiences on why clean tech businesses stall and what it takes to scale them. For speaking enquiries for 2026 and 2027, get in touch at Paul@corporate-counsel.co.uk.